Gain of function of Tbx1 affects pharyngeal and heart development in the mouse

Genesis

Volumn 47, Issue 3, 2009, Pages 188-195

  Vitelli, Francesca ^a   Huynh, Tuong ^a   Baldini, Antonio ^a,b,c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

Cardiovascular defects; Conditional expression; Fgf8; Overexpression; Pharyngeal apparatus; Tbx1

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBX1; UNCLASSIFIED DRUG; CRE RECOMBINASE; INTEGRASE; T BOX TRANSCRIPTION FACTOR; TBX1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC GAIN; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM DEFECT; MOUSE; NEWBORN DEATH; NONHUMAN; NUCLEOTIDE SEQUENCE; PHARYNX; PHENOTYPE; PRIORITY JOURNAL; THYMUS APLASIA; TRANSGENICS; ANIMAL; BIOSYNTHESIS; CHICKEN; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CROSS BREEDING; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; HEART; LETTER; MOUSE MUTANT; PHYSIOLOGY; PRENATAL DEVELOPMENT; THYMUS; TRANSGENIC MOUSE;

ANIMALIA; MAMMALIA;

ANIMALS; CHICKENS; CROSSES, GENETIC; GENE DOSAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART DEFECTS, CONGENITAL; INTEGRASES; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PHARYNX; T-BOX DOMAIN PROTEINS; THYMUS GLAND;

EID: 67049173938     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20476     Document Type: Article

References (19)

1. Aggarwal VS, Liao J, Bondarev A, Schimmang T, Lewandoski M, Locker J, Shanske A, Campione M, Morrow BE. 2006. Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy. Hum Mol Genet 15:3219-3228.
2. Baldini A. 2005. Dissecting contiguous gene defects: TBX1. Curr Opin Genet Dev 15:279-284.
3. Baldini A. 2006. The 22q11.2 deletion syndrome: A gene dosage perspective. Sci World J 6:1881-1887.
4. Brown CB, Wenning JM, Lu MM, Epstein DJ, Meyers EN, Epstein JA. 2004. Cre-mediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for Fgf8 in cardiovascular development in the mouse. Dev Biol 267:190-202.
5. Hu T, Yamagishi H, Maeda J, McAnally J, Yamagishi C, Srivastava D. 2004. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131:5491-5502.
6. Huynh T, Chen L, Terrell P, Baldini A. 2007. A fate map of Tbx1 expressing cells reveals heterogeneity in the second cardiac field. Genesis 45:470-475.
7. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27:286-291.
8. Liao J, Aggarwal VS, Nowotschin S, Bondarev A, Lipner S, Morrow BE. 2008. Identification of downstream genetic pathways of Tbx1 in the second heart field. Dev Biol 316:524-537.
9. Liao J, Kochilas L, Nowotschin S, Arnold JS, Aggarwal VS, Epstein JA, Brown MC, Adams J, Morrow BE. 2004. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet 13:1577-1585.
10. Lindsay EA. 2001. Chromosomal microdeletions: Dissecting del22q11 syndrome. Nature Rev Genet 2:858-868.
11. Lindsay EA, Botta A, Jurecic V, Carattini-Rivera S, Cheah Y-C, Rosenblatt HM, Bradley A, Baldini A. 1999. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401:379-383.
12. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, Bradley A, Baldini A. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101.
13. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Min Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S, Tokooya K, St. Jore B, Lopez M, Pandita RK, Lia M, Carrion D, Xu H, Schorle H, Kobler JB, Scambler PJ, Wynshaw-Boris A, Skoultchi AI, Morrow BE, Kucherlapati R. 2001. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619-629.
14. Park EJ, Ogden LA, Talbot A, Evans S, Cai CL, Black BL, Frank DU, Moon AM. 2006. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 133:2419-2433.
15. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain [letter]. Nat Genet 21:70-71.
16. Vitelli F, Morishima M, Taddei I, Lindsay EA, Baldini A. 2002a. Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Hum Mol Genet 11:915-922.
17. Vitelli F, Taddei I, Morishima M, Meyers EN, Lindsay EA, Baldini A. 2002b. A genetic link between Tbx1 and Fibroblast Growth Factor signaling. Development 129:4605-4611.
18. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S-i, Kamatani N, Momma K, Takao A, Nakazawa M, Shimizu N, Matsuoka R. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362:1366-1373.
19. Zhang Z, Baldini A. 2008. In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum Mol Genet 17:150-157.